SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
CZLhaust
Lv1
1
50 积分
2024-04-20 加入
最近求助
最近应助
互助留言
Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population
1小时前
待确认
Mouse models for human hyperuricaemia: a critical review
5天前
已完结
Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion
15天前
已完结
A randomized phase 2b trial examined the effects of the glucagon-like peptide-1 and glucagon receptor agonist cotadutide on kidney outcomes in patients with diabetic kidney disease
1个月前
已完结
Downregulation of the kidney glucagon receptor, essential for renal function and systemic homeostasis, contributes to chronic kidney disease
1个月前
已完结
The renal glucagon receptor is essential to kidney metabolic and homeostatic functions
1个月前
已完结
Insulin Secretion Depends on Intra-islet Glucagon Signaling
1个月前
已完结
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
1个月前
已完结
BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy
1个月前
已完结
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
1个月前
已完结
没有进行任何应助
找到了【积分已退回】
7个月前
感谢,速度真快,帮大忙了,么么哒
7个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论